184 related articles for article (PubMed ID: 32071291)
1. Azoramide protects iPSC-derived dopaminergic neurons with PLA2G6 D331Y mutation through restoring ER function and CREB signaling.
Ke M; Chong CM; Zeng H; Huang M; Huang Z; Zhang K; Cen X; Lu JH; Yao X; Qin D; Su H
Cell Death Dis; 2020 Feb; 11(2):130. PubMed ID: 32071291
[TBL] [Abstract][Full Text] [Related]
2. PARK14 (D331Y) PLA2G6 Causes Early-Onset Degeneration of Substantia Nigra Dopaminergic Neurons by Inducing Mitochondrial Dysfunction, ER Stress, Mitophagy Impairment and Transcriptional Dysregulation in a Knockin Mouse Model.
Chiu CC; Lu CS; Weng YH; Chen YL; Huang YZ; Chen RS; Cheng YC; Huang YC; Liu YC; Lai SC; Lin KJ; Lin YW; Chen YJ; Chen CL; Yeh TH; Wang HL
Mol Neurobiol; 2019 Jun; 56(6):3835-3853. PubMed ID: 30088174
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson's Disease Models.
Iannielli A; Bido S; Folladori L; Segnali A; Cancellieri C; Maresca A; Massimino L; Rubio A; Morabito G; Caporali L; Tagliavini F; Musumeci O; Gregato G; Bezard E; Carelli V; Tiranti V; Broccoli V
Cell Rep; 2018 Feb; 22(8):2066-2079. PubMed ID: 29466734
[TBL] [Abstract][Full Text] [Related]
4. Azoramide prevents MPP
Ai N; Wang D; Qu S; Vong CT; Yuan M; Su H; Ge W; Chong CM
Free Radic Biol Med; 2023 Nov; 208():299-308. PubMed ID: 37625657
[TBL] [Abstract][Full Text] [Related]
5. Azoramide ameliorated tachypacing-induced injury of atrial myocytes differentiated from human induced pluripotent stem cell by regulating endoplasmic reticulum stress.
Miao W; Shi J; Huang J; Lin Y; Cui C; Zhu Y; Zheng B; Li M; Jiang Q; Chen M
Stem Cell Res; 2022 Apr; 60():102686. PubMed ID: 35101669
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic assays identify azoramide as a small-molecule modulator of the unfolded protein response with antidiabetic activity.
Fu S; Yalcin A; Lee GY; Li P; Fan J; Arruda AP; Pers BM; Yilmaz M; Eguchi K; Hotamisligil GS
Sci Transl Med; 2015 Jun; 7(292):292ra98. PubMed ID: 26084805
[TBL] [Abstract][Full Text] [Related]
7. Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.
Cheng YC; Lin HI; Syu SH; Lu HE; Huang CY; Lin CH; Hsieh PCH
Stem Cell Res; 2019 May; 37():101432. PubMed ID: 30978640
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease-associated
Mori A; Hatano T; Inoshita T; Shiba-Fukushima K; Koinuma T; Meng H; Kubo SI; Spratt S; Cui C; Yamashita C; Miki Y; Yamamoto K; Hirabayashi T; Murakami M; Takahashi Y; Shindou H; Nonaka T; Hasegawa M; Okuzumi A; Imai Y; Hattori N
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20689-20699. PubMed ID: 31548400
[TBL] [Abstract][Full Text] [Related]
9. Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress.
Tao K; Wang B; Feng D; Zhang W; Lu F; Lai J; Huang L; Nie T; Yang Q
Neurosci Bull; 2016 Feb; 32(1):61-9. PubMed ID: 26762342
[TBL] [Abstract][Full Text] [Related]
10. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons.
Sagal J; Zhan X; Xu J; Tilghman J; Karuppagounder SS; Chen L; Dawson VL; Dawson TM; Laterra J; Ying M
Stem Cells Transl Med; 2014 Aug; 3(8):888-98. PubMed ID: 24904172
[TBL] [Abstract][Full Text] [Related]
11. The anti-aging protein klotho alleviates injury of nigrostriatal dopaminergic pathway in 6-hydroxydopamine rat model of Parkinson's disease: Involvement of PKA/CaMKII/CREB signaling.
Baluchnejadmojarad T; Eftekhari SM; Jamali-Raeufy N; Haghani S; Zeinali H; Roghani M
Exp Gerontol; 2017 Dec; 100():70-76. PubMed ID: 29107062
[TBL] [Abstract][Full Text] [Related]
12. PLA2G6 mutations cause motor dysfunction phenotypes of young-onset dystonia-parkinsonism type 14 and can be relieved by DHA treatment in animal models.
Yeh TH; Liu HF; Chiu CC; Cheng ML; Huang GJ; Huang YC; Liu YC; Huang YZ; Lu CS; Chen YC; Chen HY; Cheng YC
Exp Neurol; 2021 Dec; 346():113863. PubMed ID: 34520727
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-γ (PPARγ) agonist is neuroprotective and stimulates PGC-1α expression and CREB phosphorylation in human dopaminergic neurons.
Mäkelä J; Tselykh TV; Kukkonen JP; Eriksson O; Korhonen LT; Lindholm D
Neuropharmacology; 2016 Mar; 102():266-75. PubMed ID: 26631533
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of endoplasmic reticulum stress is involved in the neuroprotective effects of candesartan cilexitil in the rotenone rat model of Parkinson's disease.
Wu L; Tian YY; Shi JP; Xie W; Shi JQ; Lu J; Zhang YD
Neurosci Lett; 2013 Aug; 548():50-5. PubMed ID: 23774475
[TBL] [Abstract][Full Text] [Related]
15. Azoramide improves mitochondrial dysfunction in palmitate-induced insulin resistant H9c2 cells.
Okatan EN; Olgar Y; Tuncay E; Turan B
Mol Cell Biochem; 2019 Nov; 461(1-2):65-72. PubMed ID: 31327095
[TBL] [Abstract][Full Text] [Related]
16. Azoramide ameliorates fructose-induced nonalcoholic fatty liver disease in mice.
Bagci R; Sahinturk V; Sahin E
Tissue Cell; 2019 Aug; 59():62-69. PubMed ID: 31383290
[TBL] [Abstract][Full Text] [Related]
17. Geraniol Protects Against the Protein and Oxidative Stress Induced by Rotenone in an In Vitro Model of Parkinson's Disease.
Rekha KR; Inmozhi Sivakamasundari R
Neurochem Res; 2018 Oct; 43(10):1947-1962. PubMed ID: 30141137
[TBL] [Abstract][Full Text] [Related]
18. Generation of induced pluripotent stem cells from a young-onset Parkinson's disease patient carrying the compound heterozygous PLA2G6 p.D331Y/p.M358IfsX mutations.
Chiu CC; Wang HL; Weng YH; Chen RS; Chen CM; Yeh TH; Lu CS; Chen YJ; Liu YC; Huang YZ; Chang KH
Stem Cell Res; 2019 Oct; 40():101552. PubMed ID: 31493761
[TBL] [Abstract][Full Text] [Related]
19. Palmitoylethanolamide protects mice against 6-OHDA-induced neurotoxicity and endoplasmic reticulum stress: In vivo and in vitro evidence.
Avagliano C; Russo R; De Caro C; Cristiano C; La Rana G; Piegari G; Paciello O; Citraro R; Russo E; De Sarro G; Meli R; Mattace Raso G; Calignano A
Pharmacol Res; 2016 Nov; 113(Pt A):276-289. PubMed ID: 27616549
[TBL] [Abstract][Full Text] [Related]
20. Azoramide ameliorates cadmium-induced cytotoxicity by inhibiting endoplasmic reticulum stress and suppressing oxidative stress.
Zhang L; Zhang J; Zhou Y; Xia Q; Xie J; Zhu B; Wang Y; Yang Z; Li J
PeerJ; 2024; 12():e16844. PubMed ID: 38313032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
